The Nasal Covid Vaccine From Blue Lake Biotechnology Is More Effective Against Covid Infection
Blue Lake Biotechnology Inc., a startup company, developed a COVID vaccine that effectively reduces COVID symptoms. According to the results gathered from the phase I clinical trial, it gives protection for three months for people who take it as a booster dose.
86% more effective in reducing coronavirus
According to the latest news on health, the nasal vaccine developed by Blue Lake is 86% more effective in reducing the symptoms of coronavirus infections in people aged between 18 and 49 years. According to the CDCP (Centers for Disease Control and Prevention), it is more effective compared to other COVID vaccines on the market that are 43 percent effective in lowering coronavirus symptoms.
The nasal vaccine strengthens immunity
Most viruses enter the body through the nose. Scientis...